Vasopressin	vasopressin	S_chemical	O
in	in	O	O
the	the	O	O
treatment	treatment	O	O
of	of	O	O
milrinone-induced	milrinone-induced	O	O
hypotension	hypotension	O	S_disease
in	in	O	O
severe	severe	O	O
heart	heart	O	B_disease
failure	failure	O	I_disease
.	.	O	O

The	the	O	O
use	use	O	O
of	of	O	O
phosphodiesterase	phosphodiesterase	B_chemical	O
inhibitors	inhibitors	I_chemical	O
such	such	O	O
as	as	O	O
milrinone	milrinone	O	O
in	in	O	O
the	the	O	O
treatment	treatment	O	O
of	of	O	O
severe	severe	O	O
heart	heart	O	B_disease
failure	failure	O	I_disease
is	is	O	O
frequently	frequently	O	O
restricted	restricted	O	O
because	because	O	O
they	they	O	O
cause	cause	O	O
vasodilation	vasodilation	O	O
and	and	O	O
hypotension	hypotension	O	S_disease
.	.	O	O

In	in	O	O
patients	patients	O	O
with	with	O	O
decompensated	decompensated	O	O
heart	heart	O	B_disease
failure	failure	O	I_disease
with	with	O	O
hypotension	hypotension	O	S_disease
after	after	O	O
treatment	treatment	O	O
with	with	O	O
milrinone	milrinone	O	O
,	,	O	O
low	low	O	O
doses	doses	O	O
of	of	O	O
vasopressin	vasopressin	S_chemical	O
restored	restored	O	O
blood	blood	O	O
pressure	pressure	O	O
without	without	O	O
inhibiting	inhibiting	O	O
the	the	O	O
inotropic	inotropic	O	O
effect	effect	O	O
of	of	O	O
milrinone	milrinone	O	O
.	.	O	O

